###begin article-title 0
###xml 11 21 11 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">optineurin</italic>
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 57 65 <span type="species:ncbi:9606">patients</span>
Absence of optineurin (OPTN) gene mutations in Taiwanese patients with juvenile-onset open-angle glaucoma
###end article-title 0
###begin p 1
The first two authors contributed equally to this publication
###end p 1
###begin p 2
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 2
###begin title 3
Purpose
###end title 3
###begin p 4
###xml 40 50 40 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">optineurin</italic>
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 66 74 <span type="species:ncbi:9606">patients</span>
To investigate sequence variants in the optineurin (OPTN) gene in patients with juvenile-onset open-angle glaucoma (JOAG) in Taiwan.
###end p 4
###begin title 5
Methods
###end title 5
###begin p 6
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 287 291 287 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
We analyzed the sequence variants of OPTN in 51 unrelated Taiwanese probands with JOAG and in 51 control group subjects who did not have JOAG. Genomic DNA was extracted from the individuals and subjected to polymerase chain reaction (PCR) to amplify all 16 exons and flanking introns of OPTN. The amplified products were then screened for base variants by autosequence. Data from the two study groups were then compared using Fisher's exact test and Armitage's trend test.
###end p 6
###begin title 7
Results
###end title 7
###begin p 8
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 787 790 787 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;06</sup>
###xml 51 59 <span type="species:ncbi:9606">patients</span>
###xml 334 342 <span type="species:ncbi:9606">patients</span>
###xml 539 547 <span type="species:ncbi:9606">patients</span>
Fifteen variants of OPTN were found in the 51 JOAG patients and 51 unrelated normal controls. Two were missense variants (M98K and K322E), one was a synonymous codon change (T34T), and 12 were changes in the noncoding sequences. Seven of the variants have been reported and eight were novel. All of the sequence changes were found in patients with JOAG and in the normal controls except for variant c.-233+25C>G, which was found only in the control group. Allelic frequencies of these sequence changes did not differ significantly between patients and controls (p>0.05) except for the variant c.-233+25C>G (p<0.001). Genotype frequencies of c.-233+25C>G was shown to be significant between the two groups using Fisher's two-tailed exact test (p<0.001) and Armitage's trend test (p=6.815e-06).
###end p 8
###begin title 9
Conclusions
###end title 9
###begin p 10
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
Our data indicate that none of the mutations in OPTN are associated with JOAG. The variant M98K is not a risk factor and the variant c.-233+25C>G may be protective against glaucoma in Taiwanese.
###end p 10
###begin title 11
Introduction
###end title 11
###begin p 12
###xml 121 122 121 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 301 302 301 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 428 429 428 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 890 891 890 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 1214 1215 1214 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 851 859 <span type="species:ncbi:9606">patients</span>
Glaucoma is a heterogeneous group of optic neuropathies that lead to optic nerve atrophy and a permanent loss of vision [1]. Glaucoma is the second leading cause of blindness worldwide with a prevalence of 0.15% in the total population and approximately 2%-4% in individuals over the age of 40 years [2]. Glaucoma is also a multifarious disease reportedly caused by the interaction of several environmental and genetic factors [3]. The most frequent form of glaucoma is primary open-angle glaucoma (POAG). POAG is a complex disease of unknown etiology that leads to a progressive loss of the visual field. POAG has been subdivided into two groups according to the age at onset. Adult-onset open-angle glaucoma is a condition typically diagnosed after the age of 40 years; juvenile-onset open-angle glaucoma (JOAG) is a disease most often diagnosed in patients younger than 35 years of age [4]. The definition of juvenile glaucoma is not consistent in the literature. The condition is variously described as a subset of infantile glaucoma and as an early onset form of chronic open-angle glaucoma. Whether this disease actually represents a distinct clinical entity has also been questioned by several researchers [5].
###end p 12
###begin p 13
###xml 97 101 97 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 121 125 121 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 155 160 155 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 298 299 298 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
At least 14 gene loci (GLC1A-N) have been linked to POAG (OMIM ). Among these loci, three genes (MYOC encoding myocilin, OPTN encoding optineurin, and the WDR36 encoding T-cell activation WD repeat-containing protein [TAWDRP] gene) have been considered to harbor the mutations that result in POAG [6-12].
###end p 13
###begin p 14
###xml 68 72 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 91 95 91 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 248 249 248 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 256 260 256 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 415 419 415 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 547 551 547 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 783 785 783 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 801 805 801 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 880 882 880 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 686 694 <span type="species:ncbi:9606">patients</span>
###xml 870 878 <span type="species:ncbi:9606">patients</span>
Primary open angle glaucoma-1E (GLC1E) is caused by mutation in the OPTN gene (OMIM ). The OPTN gene locus was mapped to chromosome 10p15-p14 by linkage analysis of the gene in a large British family with a classic form of normal tension glaucoma [9]. The OPTN gene consists of 16 exons; the first three are noncoding exons in the 5' untranslated region followed by 13 exons that code for a 577 amino acid protein. OPTN is expressed in ocular tissues such as the retina, trabecular meshwork, and nonpigmented ciliary epithelium [13]. Mutations in OPTN, arguably the second POAG gene, were initially found in 16.7% of families with hereditary and adult-onset POAG and in 12% of sporadic patients with POAG. The majority of them had an intraocular pressure (IOP) of less than 22 mmHg [13]. Mutations in OPTN were also found to account for 1.6% of sporadic POAG in Chinese patients [14].
###end p 14
###begin p 15
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 551 553 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 623 625 623 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 663 667 663 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 799 803 799 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 120 126 <span type="species:ncbi:9606">people</span>
###xml 137 143 <span type="species:ncbi:9606">people</span>
###xml 902 910 <span type="species:ncbi:9606">patients</span>
Previous studies in Western populations show a significant racial/ethnic variation in glaucoma prevalence between white people and black people, largely related to variation in the prevalence of primary open-angle glaucoma (POAG) [15-17]. Until recently, similar data have been described in Asian populations [18]. Based on the survey of low vision (WHO criteria), the prevalence of primary open-angle glaucoma in the elderly Chinese was about 2% in Taiwan [19]. In another study, glaucoma was the leading cause of low vision and blindness in Taiwan [20]. However, the gene study of glaucoma just begin to be investigated [21] and the contribution of variants in OPTN for JOAG in Taiwan is currently unknown. In this study, we aimed to determine the variants of the 16 exons and flanking introns of OPTN using comparative genetic analysis between genomic DNA from unrelated normal individuals and JOAG patients in Taiwan.
###end p 15
###begin title 16
Methods
###end title 16
###begin title 17
Subject selection
###end title 17
###begin p 18
###xml 910 914 910 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 998 1002 998 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 1046 1048 1046 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 1078 1082 1078 1082 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 17 25 <span type="species:ncbi:9606">patients</span>
###xml 155 163 <span type="species:ncbi:9606">patients</span>
###xml 323 331 <span type="species:ncbi:9606">Patients</span>
###xml 835 843 <span type="species:ncbi:9606">patients</span>
###xml 851 859 <span type="species:ncbi:9606">patients</span>
###xml 881 888 <span type="species:ncbi:9606">patient</span>
###xml 1026 1034 <span type="species:ncbi:9606">patients</span>
A total of 1,210 patients who presented to the Department of Ophthalmology at the Kuo General Hospital with symptoms of glaucoma were evaluated. All study patients received more than two complete ocular examinations, each comprising slit-lamp testing, IOP measurement, a fundus examination, and a visual-field examination. Patients were defined as having JOAG if they were first diagnosed before the age of 35 years and found to have an intraocular pressure (IOP) greater than 22 mmHg, a cup/disc ratio greater than 0.5 or one with an asymmetric appearance, a visual-field loss characteristic of glaucomatous change, and an open-angle width ranging from Shaffer grade II to IV without any other apparent secondary cause (e.g., traumatically or surgically induced). Of the 1,210 individuals screened, JOAG was diagnosed in 51 unrelated patients. These patients were included in the patient group for subsequent OPTN genetic analysis. Most of these subjects have been reported in a previous study of MYOC mutations in Taiwanese patients with JOAG [20]. Subjects with mutations in MYOC were also included in the study.
###end p 18
###begin p 19
###xml 473 485 <span type="species:ncbi:9606">participants</span>
Fifty-one randomly selected normal individuals over 50 years of age were included as the control group. None of them featured JOAG. Individuals in the control group also received complete ocular examinations as described above to exclude the possibility of glaucoma. The study protocol was approved by the Institutional Review Board of the Kuo General Hospital and was performed in accordance with the World Medical Association's Declaration of Helsinki (2000). All of the participants provided signed informed consent to participate in the study after details of the study were thoroughly explained to them.
###end p 19
###begin title 20
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
Detection of mutations in OPTN
###end title 20
###begin p 21
###xml 400 404 400 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 530 537 530 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 1145 1149 1142 1146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
DNA samples were collected from 10 ml of peripheral blood acquired from each of the 102 individuals and purified using a Gentra DNA Blood Kit (Gentra Systems Inc., Minneapolis, MN) according to the manufacturer's directions. The quality and quantity of purified genomic DNA were determined by gel electrophoresis and spectrophotometry, respectively. Mutations in the 16 exons and flanking introns of OPTN were screened by direct sequencing (GenBank ). The intragenic primers used for polymerase chain reaction (PCR) are listed in Table 1. In brief, PCR was performed in a reaction volume of 25 mul containing 100 ng of genomic DNA, 200 muM dNTP, 0.25 units of proTaq DNA polymerase (Promega Corporation, Madison, WI), and 200 muM of intragenic primers. The PCR products were purified using a PCR Purification Kit (QIAGEN GmbH, Hilden, Germany) and then subjected to PCR-directed DNA sequencing using a DNA Sequencing Kit (Applied Biosystems Corporation, Foster City, CA). Sequencing was performed on an Applied Biosystems model 377 automated sequencer (Applied Biosystems Corporation). Sequence data were compared with the published sequence of OPTN (GenBank  and ).
###end p 21
###begin title 22
Oligonucleotide primer pairs for polymerase chain reaction.
###end title 22
###begin p 23
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
Primers were used in the amplification of OPTN exons and were used in sequencing reactions. Primers located in introns were placed far enough away from the exon boundaries to allow visualization of the sequence of the splice site. In the table, "F" indicates the forward strand and "R" indicates the reverse strand. In additional, bp represents base pair and DMSO represents dimethylsulfoxide in this table.
###end p 23
###begin title 24
Statistical analysis
###end title 24
###begin p 25
###xml 477 478 475 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 59 67 <span type="species:ncbi:9606">patients</span>
###xml 174 182 <span type="species:ncbi:9606">patients</span>
###xml 362 370 <span type="species:ncbi:9606">patients</span>
Significant differences in allele frequencies between JOAG patients and controls were determined by the Fisher's two-tailed exact test. The genotype frequencies between JOAG patients and controls were determined by Fisher's two-tailed exact test and Armitage's trend test. A p value less than 0.05 represented a statistically significant difference between JOAG patients and control individuals. Variants were tested for Hard-Weinberg Equilibrium (HWE) using the normal 2x3 Chi2 1 degree of freedom (df) test of goodness-of-fit to HW proportions.
###end p 25
###begin title 26
Results
###end title 26
###begin p 27
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 494 501 494 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 148 155 <span type="species:ncbi:9606">patient</span>
###xml 185 193 <span type="species:ncbi:9606">patients</span>
###xml 235 243 <span type="species:ncbi:9606">patients</span>
###xml 450 458 <span type="species:ncbi:9606">patients</span>
This study surveyed mutations in all 16 exons of OPTN including the flanking intronic sequences and coding region in 102 Taiwanese individuals. The patient group comprised 51 unrelated patients with JOAG (30 males and 21 females). The patients ranged in age from 17 to 61 years at the time of the study. There were 51 unrelated individuals (28 males and 23 females) without any evidence of glaucoma in the control group. The clinical features of the patients and control subjects are listed in Table 2.
###end p 27
###begin title 28
###xml 28 40 <span type="species:ncbi:9606">participants</span>
Clinical characteristics of participants.
###end title 28
###begin p 29
###xml 72 80 <span type="species:ncbi:9606">patients</span>
Clinical characteristics of 102 Taiwanese individuals including 51 JOAG patients under topical anti-glaucoma agent medication and 51 unrelated normal controls are listed in the table. IOP indicates intraocular pressure; C/D indicates cup-disc ratio of the optic nerve; OD indicates right eye; OS indicates left eye; and SD indicates standard deviation.
###end p 29
###begin p 30
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 102 109 102 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 465 472 465 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 825 832 825 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 999 1006 999 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 1054 1058 1054 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 59 67 <span type="species:ncbi:9606">patients</span>
###xml 521 529 <span type="species:ncbi:9606">patients</span>
###xml 719 727 <span type="species:ncbi:9606">patients</span>
###xml 860 868 <span type="species:ncbi:9606">patients</span>
###xml 929 937 <span type="species:ncbi:9606">patients</span>
###xml 1083 1091 <span type="species:ncbi:9606">patients</span>
Fifteen sequence changes of OPTN were found in the 51 JOAG patients and 51 unrelated normal controls (Table 3). Two were missense changes, one was a synonymous codon change, and 12 were changes in the noncoding sequence. Apart from T34T, M98K, c.553-5C>T, c.553-10G>A, c.626+24G>A, c.779+20G>A, and c.1979-48C>A, the other eight sequence changes (c.-284G>A, c.-105G.>A, c.964A>G, c.-233+25C>G, c.166+66A>G, c.708-53T>C, c.882+109A>G, and c.1978+101A>C) were novel (Table 3). All of the sequence changes were found in the patients with JOAG and in the normal controls except for variant c.-233+25C>G, which was found only in the control group. However, the homozygous c.-105G>A variant was observed in three of the JOAG patients. In contrast, the homozygous c.-105G>A variant was found only in the normal control individuals (Table 4. M98K was identified in 17 patients with JOAG and in 14 normal control individuals. Five of the patients and two of the control individuals were homozygous for M98K (Table 4. In addition, the c.A964A<G (K322E) variant of OPTN was found in all of the patients with JOAG and in all of the normal controls in our study. All variants were found to be consistent with Hardy-Weinberg equilibrium expectations.
###end p 30
###begin title 31
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
Variants of the OPTN gene in this study.
###end title 31
###begin p 32
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 56 64 <span type="species:ncbi:9606">patients</span>
Fifteen variants of OPTN were determined in the 51 JOAG patients and 51 unrelated normal controls. Two were missense variants (M98K and K322E), one was a synonymous codon change (T34T), and 12 were changes in the noncoding sequences. In addition, seven of the variants have been reported that it was indicated in reference position and eight were novel. The "N" indicates that the variant had no change in amino acid. The "dash" indicates that the variant had no determined effect.
###end p 32
###begin title 33
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 46 54 <span type="species:ncbi:9606">patients</span>
Genotype frequencies of OPTN variants in JOAG patients and normal control individuals.
###end title 33
###begin p 34
###xml 68 69 68 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</italic>
###xml 76 77 76 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 77 78 77 78 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 743 751 <span type="species:ncbi:9606">patients</span>
Fisher's two-tailed exact test (p Value*) and Armitage's trend test (p Value#) were used to compare the genotype frequencies of various sequence changes between JOAG and control subjects. Genotype frequency of c.-284G>A variant was shown to be significant between two groups using Fisher's two-tailed exact test (p=0.023; p<0.05). However, we used Armitage's trend test to compare the genotypic frequency of the c.-284G>A variant was not significant (p=0.153). In addition, the c.-233+25C>G genotype frequency was shown to be significant between two groups using Fisher's two-tailed exact test (p<0.001) and Armitage's trend test (p=6.815e-06). Apart from c.-284G>A and c.-233+25C>G, the other 13 variants did not differ significantly between patients and controls (p>0.05).
###end p 34
###begin p 35
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 491 498 491 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t5">Table 5</xref>
###xml 600 604 600 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 660 664 660 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 773 780 773 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 1005 1008 1005 1008 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;06</sup>
###xml 64 72 <span type="species:ncbi:9606">patients</span>
###xml 418 426 <span type="species:ncbi:9606">patients</span>
###xml 974 982 <span type="species:ncbi:9606">patients</span>
To understand the distribution of OPTN sequence changes in JOAG patients and normal control individuals, we used Fisher's two-tailed exact test to compare the allelic and genotypic frequencies of the sequence changes between the two groups. Genotype frequencies were consistent with HWE proportions for all variants. We found that the allelic frequencies of these sequence changes did not differ significantly between patients and controls (p>0.05) except for variant c.-233+25C>G (p<0.001; Table 5. However, we observed that the c.-284G>A variant (p=0.023) and the c.-233+25C>G variant (p<0.001) of OPTN was associated with JOAG whereas the other variants of OPTN were not associated with JOAG in genotypic frequency analysis using Fisher's two-tailed exact test (p>0.05; Table 4. Further, we used Armitage's trend test to compare the genotypic frequencies of the c.-284G>A and c.-233+25C>G variants between the two groups. The variant c.-233+25C>G was significant between patients and controls (p=6.815e-06), but variant c.-284G>A was not significant (p=0.153). In additional, we included another 51 control individuals for the c.-284G>A variant. We found the c.-284G>A variant in 30 normal control individuals, including five (4.9%; 5/102) who were homozygous and 25 (24.5%; 25/102) who were heterozygous. These results, the allelic and genotypic frequencies of the c.-284G>A variant between the two groups, are similar with the 51 normal control individuals (data not shown). Taken together, we suggested that the c.-284G>A variant may not be a risk factor for JOAG and the c.-233+25C>G variant may be protective against glaucoma in the Taiwanese.
###end p 35
###begin title 36
###xml 22 26 22 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
Allele frequencies of OPTN variants in this study.
###end title 36
###begin p 37
All subjects were screened and scored for each variant listed. Fisher's two-tailed exact test was used to compare the allele frequencies of various sequence changes between JOAG and control subjects. The genotype numbers indicate homozygote variant/heterozygote variant/no variant.
###end p 37
###begin title 38
Discussion
###end title 38
###begin p 39
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 154 158 154 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 242 246 242 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 273 275 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 307 311 307 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 412 416 412 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 204 212 <span type="species:ncbi:9606">patients</span>
###xml 432 440 <span type="species:ncbi:9606">patients</span>
Information regarding the role that MYOC and OPTN play in the development of JOAG in Taiwanese is insufficient. In our previous study, we identified four MYOC mutations and six polymorphisms in Taiwanese patients with JOAG. The prevalence of MYOC gene mutations was 12.5% [21]. However, the contribution of OPTN sequence variations to JOAG in Taiwan has not been analyzed. In this study, we found 15 variants of OPTN in the 51 JOAG patients and in the 51 unrelated normal controls. Two were missense variants (M98K and K322E), one was a synonymous codon change (T34T), and 12 were changes in the noncoding sequences.
###end p 39
###begin p 40
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 113 115 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 137 141 137 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 246 248 246 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 249 251 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 393 395 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 489 491 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 607 611 607 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 181 189 <span type="species:ncbi:9606">patients</span>
###xml 748 755 <span type="species:ncbi:9606">patient</span>
In previous studies, at least seven mutations of OPTN have been reported to be associated with adult-onset POAG [13,14,22]. Of the seven OPTN mutations that have been identified in patients with adult-onset POAG, one is located in exon 4 (E50K) [13,21], one is located in exon 5 (E103D) [14], two are located in exon 6 (c.691_692insAG and V148V) [13,14,22], one is located in exon 14 (H486R) [14], one is located in exon 16 (R545Q) [13,22], and one is located in intron 13 (IVS 13+21C>G) [14]. Although none of the aforementioned mutations were detected in this study, we identified 15 sequence variants of OPTN. These sequence changes are not classified as causative mutations but as polymorphisms because the frequencies were similar between the patient and normal control groups.
###end p 40
###begin p 41
###xml 50 54 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 178 182 178 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 531 535 531 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 650 654 650 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 656 658 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 718 722 718 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 777 779 777 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 845 847 845 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 864 868 864 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 936 940 936 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 221 229 <span type="species:ncbi:9606">patients</span>
###xml 284 292 <span type="species:ncbi:9606">patients</span>
###xml 374 382 <span type="species:ncbi:9606">patients</span>
###xml 408 416 <span type="species:ncbi:9606">patients</span>
###xml 477 485 <span type="species:ncbi:9606">patients</span>
###xml 551 559 <span type="species:ncbi:9606">patients</span>
###xml 748 756 <span type="species:ncbi:9606">patients</span>
###xml 899 907 <span type="species:ncbi:9606">patients</span>
Previous reports have indicated that mutations of OPTN are responsible for moderate to mild forms of late onset glaucoma and are specific for normal tension glaucoma (NTG) [13]. OPTN mutations have been found in 16.7% of patients with the hereditary form of NTG and in about 1%-2% of patients with sporadic POAG [13,14,23]. However, two subsequent studies on Caucasian POAG patients, one study involving 801 patients of variable age onset [23] and one involving 86 adult-onset patients [24], found no glaucoma-causing mutations in OPTN. In Japan, 148 patients with NTG and 165 with hypertension glaucoma had no specific glaucoma-causing mutations in OPTN [25]. In addition, a report also indicated that no mutation of OPTN was associated with JOAG patients in the Philippines [26]. Our results are consistent with those reported by Wang et al. [26] who found that OPTN mutations were absent in JOAG patients. Therefore, we suggest that OPTN mutations are not related to the development of JOAG in Taiwanese.
###end p 41
###begin p 42
###xml 290 292 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 894 896 894 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 990 994 990 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 1145 1147 1145 1147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 1262 1264 1262 1264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 1265 1267 1265 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 1281 1283 1281 1283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 1311 1313 1311 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 1405 1407 1405 1407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 1784 1788 1784 1788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 68 76 <span type="species:ncbi:9606">patients</span>
###xml 165 173 <span type="species:ncbi:9606">patients</span>
###xml 341 349 <span type="species:ncbi:9606">patients</span>
###xml 493 501 <span type="species:ncbi:9606">patients</span>
###xml 578 586 <span type="species:ncbi:9606">patients</span>
###xml 733 741 <span type="species:ncbi:9606">patients</span>
###xml 1068 1076 <span type="species:ncbi:9606">patients</span>
###xml 1503 1511 <span type="species:ncbi:9606">patients</span>
###xml 1580 1588 <span type="species:ncbi:9606">patients</span>
The M98K variant of OPTN was reported to be associated with POAG in patients with normal or elevated IOP. The allele frequency of the M98K variant was 13.6% in POAG patients and only 2.1% in the control population. The result indicated that M98K was very strongly associated with glaucoma [13]. In our study, M98K was found in 33.3% of JOAG patients (17/51) and 27.5% of individuals in the control group (14/51); however, the frequency of the M98K variant did not differ significantly between patients and controls (p=0.571). In fact, investigations of the OPTN M98K variant in patients with POAG have yielded conflicting findings so far. Recently, a meta-analysis of all published works to date on the OPTN M98K variant in glaucoma patients did not show a strong role for the OPTN M98K variant in glaucoma, autosomal dominant optic atrophy (ADOA), or Leber hereditary optic neuropathy (LHON) [27]. In addition, a large study that investigated the allele frequencies of the M98K variant in OPTN also found no significant differences in allele frequencies between POAG patients and controls in Asian, African, Hispanic, or Caucasian populations [22]. However, some studies have indicated that the M98K variant is associated with POAG within populations in Japan [22,28] and Europe [29]. Thus, Ayala-Lugo et al. [22] suggested that ancestry is a significant confounding variable. In addition, Melki et al. [30] reported that M98K was associated with decreased initial intraocular pressure (IOP) in French patients but was not significantly associated with decreased IOP in Moroccan patients. Therefore, we believe that the association between the M98K variant and glaucoma can be attributed to racial variation. Based on our results and those from previous studies, the M98K variant of OPTN is not a risk factor associated with JOAG in Taiwan.
###end p 42
###begin p 43
###xml 478 481 478 481 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;06</sup>
###xml 492 499 492 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 504 511 504 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t5">Table 5</xref>
###xml 959 963 959 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 1047 1055 <span type="species:ncbi:9606">patients</span>
In our study, the c.-233+25C>G variant was identified in the 19 normal control individuals but was not found in the JOAG individuals. Thirteen of the control individuals (25.5%; 13/51) were homozygous, and six of the control individuals (11.8%; 6/51) were heterozygous for c.-233+25C>G. The c.-233+25C>G allele frequencies and genotype frequencies were shown to be significant between two groups using Fisher's two-tailed exact test (p<0.001) and Armitage's trend test (p=6.815e-06; shown in Table 4 and Table 5). Therefore, we suggest that the c.-233+25C>G variant may be protective against glaucoma in the Taiwanese. Further research into this association would be interesting. Expression studies and functional assays may be needed to determine whether these sequence variants play a role as transcription activators or inhibitors. This might ultimately shed light on the mechanisms relevant to the development of glaucoma. In addition, A964 nucleotide of OPTN has been reported in GenBank . In contrast, the G964 nucleotides were found in all patients with JOAG and in all normal controls in our study. One possible explanation for such a difference in nucleotides is attributed to racial variations. Therefore, the c.964A>G variant is not associated with JOAG.
###end p 43
###begin title 44
Acknowledgments
###end title 44
###begin p 45
We would like to thank all of the subjects who participated in the present project. This study was partly supported by a Chi-Mei Medical Center Liouying Research Grant (CLFHR 9627).
###end p 45
###begin title 46
Reference
###end title 46
###begin article-title 47
Progress in the genetics of glaucoma.
###end article-title 47
###begin article-title 48
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 70 78 <span type="species:ncbi:9606">patients</span>
Escribano Julio. Role of MYOC and OPTN sequence variations in Spanish patients with Primary Open-Angle Glaucoma.
###end article-title 48
###begin article-title 49
Anterior segment dysgenesis and the developmental glaucomas are complex traits.
###end article-title 49
###begin article-title 50
A common gene for juvenile and adult-onset primary open-angle glaucomas confined on chromosome 1q.
###end article-title 50
###begin article-title 51
Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1.
###end article-title 51
###begin article-title 52
###xml 39 44 <span type="species:ncbi:9606">human</span>
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
Characterization and comparison of the human and mouse GLC1A glaucoma genes.
###end article-title 52
###begin article-title 53
Genetic linkage of familial open angle glaucoma to chromosome 1q21-q31.
###end article-title 53
###begin article-title 54
Identification of a new 'TIGR' mutation in a family with juvenile-onset primary open angle glaucoma.
###end article-title 54
###begin article-title 55
Localization of the fourth locus (GLC1E) for adult-onset primary open-angle glaucoma to the 10p15-p14 region.
###end article-title 55
###begin article-title 56
Genetic dissection of myocilin glaucoma.
###end article-title 56
###begin article-title 57
A new locus (GLC1H) for adult-onset primary open-angle glaucoma maps to the 2p15-p16 region.
###end article-title 57
###begin article-title 58
Gene mapping for primary open angle glaucoma.
###end article-title 58
###begin article-title 59
Adult-onset primary open-angle glaucoma caused by mutations in optineurin.
###end article-title 59
###begin article-title 60
###xml 133 141 <span type="species:ncbi:9606">patients</span>
Tam POS, Chua JKH, Tham CCY, Lai JSM, Fan DSP, Pang CP. Different optineurin mutation pattern in Chinese primary open angle glaucoma patients.
###end article-title 60
###begin article-title 61
Causes and prevalence of visual impairment among adults in the United States.
###end article-title 61
###begin article-title 62
The prevalence of refractive errors among adults in the United States,Western Europe, and Australia.
###end article-title 62
###begin article-title 63
Prevalence of open-angle glaucoma among adults in the United States.
###end article-title 63
###begin article-title 64
The epidemiology of age related eye diseases in Asia.
###end article-title 64
###begin article-title 65
Prevalence and causes of visual impairment in an elderly Chinese population in Taiwan: the Shihpai Eye Study.
###end article-title 65
###begin article-title 66
Trends in blind and low vision registrations in Taipei City.
###end article-title 66
###begin article-title 67
###xml 35 50 35 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myocilin (MYOC)</italic>
###xml 69 77 <span type="species:ncbi:9606">patients</span>
Identification of mutations in the myocilin (MYOC) gene in Taiwanese patients with juvenile-onset open-angle glaucoma.
###end article-title 67
###begin article-title 68
###xml 13 30 13 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">optineurin (OPTN)</italic>
Variation in optineurin (OPTN) allele frequencies between and within populations.
###end article-title 68
###begin article-title 69
###xml 54 62 <span type="species:ncbi:9606">patients</span>
Evaluation of optineurin sequence variations in 1,048 patients with open-angle glaucoma.
###end article-title 69
###begin article-title 70
###xml 63 71 <span type="species:ncbi:9606">patients</span>
Lack of association of mutations in optineurin with disease in patients with adult-onset primary open-angle glaucoma.
###end article-title 70
###begin article-title 71
###xml 89 97 <span type="species:ncbi:9606">patients</span>
The association between Japanese primary open-angle glaucoma and normal tension glaucoma patients and the optineurin gene.
###end article-title 71
###begin article-title 72
Absence of myocilin and optineurin mutations in a large Philippine family with juvenile onset primary open angle glaucoma.
###end article-title 72
###begin article-title 73
The role of the Met98Lys optineurin variant in inherited optic nerve diseases.
###end article-title 73
###begin article-title 74
Molecular genetic analysis of optineurin gene for primary open-angle and normal tension glaucoma in the Japanese population.
###end article-title 74
###begin article-title 75
Astakhov IuS, Kvasova MD, Vasil'ev VB, Golubkov VI, Mandel'shtam MIu. Mutations and polymorphisms in the genes for myocilin and optineurin as the risk factors of primary open-angle glaucoma.
###end article-title 75
###begin article-title 76
###xml 88 96 <span type="species:ncbi:9606">patients</span>
The M98K variant of the OPTINEURIN (OPTN) gene modifies initial intraocular pressure in patients with primary open angle glaucoma.
###end article-title 76
###begin article-title 77
Jarvela. The role of TIGR and OPTN in Finnish glaucoma families: a clinical and molecular genetic study.
###end article-title 77

